BCDA · BioCardia, Inc.
What's happening
- BCDA is down 5.92% today, trading at $0.98. — Live quote
- Volume today (342) is well below its 3-month average of 461,570. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.13 actual vs. $-0.18 estimated (+29.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | — | $12.5M | — | $10.3M | $11.6M |
| P/E | — | -1.47 | — | -1.27 | -1.39 |
| Price/Book | — | -11.76 | — | -5.49 | -7.65 |
| EV/EBITDA | — | -1.36 | — | — | — |
| ROE | — | 797.65% | — | 431.81% | 550.13% |
| ROA | — | -496.67% | — | -389.85% | -386.06% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-20; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -1985.8%. Finnhub fundamentals ↗
- Trailing 52-week price return is -38.1%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on BCDA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$1.6M | -$2.3M | -$1.5M | -$2.1M | -$2.7M | -$1.8M | -$1.6M | -$2.3M |
| Net income | -$1.6M | -$2.3M | -$1.5M | -$2.0M | -$2.7M | -$1.7M | -$1.6M | -$2.3M |
| EPS (diluted) | — | $-0.21 | — | $-0.40 | $-0.59 | — | — | — |
| EPS (basic) | $-0.13 | $-0.21 | $-0.24 | $-0.40 | $-0.59 | $-0.61 | $-0.88 | $-1.35 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $4.8M | $1.7M | $3.4M | $6.1M | $2.1M | $2.2M | $3.7M | $6.3M |
| Total liabilities | $2.1M | $2.8M | $2.5M | $3.5M | $4.0M | $3.7M | $2.9M | $3.5M |
| Stockholders' equity | $2.7M | -$1.1M | $895.0K | $2.6M | -$1.9M | -$1.5M | $837.0K | $2.8M |
| Total current assets | $4.3M | $1.1M | $2.7M | $5.4M | $1.2M | $1.2M | $2.6M | $5.1M |
| Total current liabilities | $2.1M | $2.8M | $2.4M | $3.3M | $3.6M | $3.2M | $2.3M | $2.8M |
| Cash & equivalents | $4.1M | $951.0K | $2.5M | $5.3M | $980.0K | $949.0K | $2.4M | $4.9M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $30.0K | $20.0K | $20.0K | — | $10.0K | — | $0 | $10.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $13.0K | $16.0K | $16.0K | $13.0K | $17.0K | $16.0K | $33.0K | $47.0K |
| Other non-current assets | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K | $171.0K |
| Accounts payable | $541.0K | $820.0K | $641.0K | $1.1M | $1.2M | $818.0K | $385.0K | $569.0K |
| Accrued liabilities | $30.0K | $52.0K | $34.0K | $108.0K | $41.0K | $243.0K | $22.0K | $28.0K |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $15.0K | $11.0K | $11.0K | $11.0K | $6.0K | $5.0K | $5.0K | $5.0K |
| Retained earnings | -$172.2M | -$170.6M | -$168.3M | -$166.4M | -$164.9M | -$162.8M | -$160.1M | -$157.8M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.7M | -$1.7M | -$2.5M | -$1.7M | -$1.6M | -$1.6M | -$2.4M | -$2.6M |
| Investing cash flow | $0 | -$3.0K | -$6.0K | $0 | -$1.0K | $0 | -$1.0K | -$2.0K |
| Financing cash flow | $4.9M | $117.0K | -$288.0K | $6.0M | $1.7M | $196.0K | -$125.0K | $6.1M |
| Free cash flow | -$1.7M | -$1.7M | -$2.5M | -$1.7M | -$1.6M | -$1.6M | -$2.4M | -$2.6M |
| Capital expenditures | $0 | $3.0K | $6.0K | $0 | $1.0K | $0 | $1.0K | $2.0K |
| Depreciation & amortization | $3.0K | $3.0K | $3.0K | $4.0K | $5.0K | $12.0K | $15.0K | $16.0K |
| Share-based compensation | $109.0K | $113.0K | $85.0K | $77.0K | $98.0K | $170.0K | $176.0K | $177.0K |
| Change in accounts receivable | $10.0K | — | $20.0K | -$10.0K | $10.0K | $0 | -$10.0K | $0 |
| Change in inventory | — | — | — | — | — | — | — | — |
| Change in accounts payable | -$255.0K | $247.0K | -$365.0K | -$213.0K | $319.0K | $422.0K | -$151.0K | -$726.0K |
| Debt issued | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | $197.0K | — | — | — | $140.0K | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$8.3M | -$8.0M | -$11.6M | -$11.9M | -$12.6M |
| Net income | -$8.2M | -$7.9M | -$11.6M | -$11.9M | -$12.6M |
| EPS (basic) | $-1.23 | $-2.90 | $-8.19 | $-0.67 | $-0.75 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $3.4M | $3.7M | $3.0M | $9.8M | $15.7M |
| Total liabilities | $2.5M | $2.9M | $4.6M | $4.9M | $5.3M |
| Stockholders' equity | $895.0K | $837.0K | -$1.6M | $4.9M | $10.4M |
| Total current assets | $2.7M | $2.6M | $1.5M | $7.9M | $13.5M |
| Total current liabilities | $2.4M | $2.3M | $3.6M | $3.6M | $3.7M |
| Cash & equivalents | $2.5M | $2.4M | $1.1M | $7.4M | $12.9M |
| Accounts receivable | $20.0K | $0 | $63.0K | $201.0K | $147.0K |
| Inventory | — | — | — | — | — |
| Property, plant & equipment | $16.0K | $33.0K | $94.0K | $170.0K | $182.0K |
| Other non-current assets | $171.0K | $171.0K | $171.0K | $171.0K | $172.0K |
| Accounts payable | $641.0K | $385.0K | $890.0K | $683.0K | $507.0K |
| Accrued liabilities | $34.0K | $22.0K | $75.0K | $157.0K | $240.0K |
| Deferred revenue (current) | — | — | $0 | $341.0K | $847.0K |
| Common stock & paid-in capital | $11.0K | $5.0K | $2.0K | $20.0K | $17.0K |
| Retained earnings | -$168.3M | -$160.1M | -$152.2M | -$140.6M | -$128.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$7.4M | -$7.9M | -$10.0M | -$10.6M | -$10.4M |
| Investing cash flow | -$7.0K | -$6.0K | -$12.0K | -$70.0K | -$116.0K |
| Financing cash flow | $7.6M | $9.2M | $3.7M | $5.1M | $1.9M |
| Free cash flow | -$7.4M | -$7.9M | -$10.0M | -$10.6M | -$10.5M |
| Capital expenditures | $7.0K | $6.0K | $12.0K | $70.0K | $116.0K |
| Depreciation & amortization | $24.0K | $67.0K | $84.0K | $82.0K | $60.0K |
| Share-based compensation | $430.0K | $741.0K | $1.0M | $1.2M | $1.7M |
| Change in accounts receivable | $20.0K | -$97.0K | -$115.0K | $54.0K | -$85.0K |
| Change in inventory | — | — | — | — | $0 |
| Change in accounts payable | $163.0K | -$316.0K | $184.0K | $4.0K | -$239.0K |
| Tax withholding on stock comp | $197.0K | $140.0K | — | — | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding BCDA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-06-17 to 2026-10-16
Recent transactions
- Insiders have net bought 145,700 shares over the last 182 days, across 19 purchases and 0 sales.
- Most recent: Altman Peter (President and CEO) — Open market purchase of 300 shares on 2026-10-16.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Altman Peter | President and CEO | Open market purchase | 2026-10-16 | 300 |
| McClung David | Chief Financial Officer | Tax withholding | 2026-07-02 | 23,125 |
| GILLIS EDWARD M | Senior Vice President, Devices | Tax withholding | 2026-07-02 | 17,269 |
| STERTZER SIMON H | Director | Open market purchase | 2026-06-23 | 39,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-16 | Altman Peter | President and CEO | Open market purchase | 300 | $0.95 |
| 2026-10-15 | Altman Peter | President and CEO | Open market purchase | 200 | $0.95 |
| 2026-09-29 | Altman Peter | President and CEO | Open market purchase | 1,000 | $1.03 |
| 2026-09-23 | Altman Peter | President and CEO | Open market purchase | 1,900 | $1.05 |
| 2026-09-03 | Altman Peter | President and CEO | Open market purchase | 800 | $1.09 |
| 2026-08-17 | Altman Peter | President and CEO | Open market purchase | 5,400 | $0.93 |
| 2026-08-13 | Altman Peter | President and CEO | Open market purchase | 1,900 | $0.92 |
| 2026-07-29 | Altman Peter | President and CEO | Open market purchase | 5,000 | $0.78 |
| 2026-07-17 | Altman Peter | President and CEO | Open market purchase | 500 | $0.83 |
| 2026-07-15 | Altman Peter | President and CEO | Open market purchase | 1,500 | $0.86 |
| 2026-07-14 | Altman Peter | President and CEO | Open market purchase | 2,800 | $0.88 |
| 2026-07-10 | Altman Peter | President and CEO | Open market purchase | 1,000 | $0.94 |
| 2026-07-09 | Altman Peter | President and CEO | Open market purchase | 1,000 | $0.90 |
| 2026-07-08 | Altman Peter | President and CEO | Open market purchase | 5,500 | $0.97 |
| 2026-07-08 | Altman Peter | President and CEO | Open market purchase | 5,400 | $0.96 |
| 2026-07-02 | Altman Peter | President and CEO | Tax withholding | 54,606 | $1.24 |
| 2026-07-02 | McClung David | Chief Financial Officer | Tax withholding | 23,125 | $1.24 |
| 2026-07-02 | GILLIS EDWARD M | Senior Vice President, Devices | Tax withholding | 17,269 | $1.24 |
| 2026-06-29 | Altman Peter | President and CEO | Grant / award | 110,625 | $1.20 |
| 2026-06-29 | McClung David | Chief Financial Officer | Grant / award | 60,483 | $1.20 |
| 2026-06-29 | GILLIS EDWARD M | Senior Vice President, Devices | Grant / award | 39,521 | $1.20 |
| 2026-06-23 | STERTZER SIMON H | Director | Open market purchase | 39,000 | $1.00 |
| 2026-06-22 | STERTZER SIMON H | Director | Open market purchase | 70,200 | $0.92 |
| 2026-06-18 | Altman Peter | President and CEO | Open market purchase | 800 | $0.96 |
| 2026-06-17 | Altman Peter | President and CEO | Open market purchase | 1,500 | $0.85 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:57 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-20 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-19 | 8-K | 2026-10-19 | View on SEC.gov → |
| 2026-10-07 | 8-K | 2026-10-07 | View on SEC.gov → |
| 2026-10-01 | 8-K | 2026-10-01 | View on SEC.gov → |
| 2026-09-30 | 4 | 2026-09-29 | View on SEC.gov → |
| 2026-09-23 | 4 | 2026-09-23 | View on SEC.gov → |
| 2026-09-23 | 8-K | 2026-09-23 | View on SEC.gov → |
| 2026-09-21 | 8-K | 2026-09-21 | View on SEC.gov → |
| 2026-09-10 | 8-K | 2026-09-10 | View on SEC.gov → |
| 2026-09-04 | 4 | 2026-09-03 | View on SEC.gov → |
| 2026-08-24 | 8-K | 2026-08-24 | View on SEC.gov → |
| 2026-08-21 | 8-K | 2026-08-19 | View on SEC.gov → |
Recent news
Headlines about BCDA (BioCardia, Inc.). Links open the publisher — we don’t host full articles.
-
SUNS,BNL,BCDA,FG,NTHI,ZOMDF,BATRA,ATLO,OPAL,NEOG,PEB,SAIC,INNV,NEWT,MTDR,VG,LUCK,GROV,EVH,AWRE,IRIX,BUSE,RNXT,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,BNL,BCDA,FG,ZOMDF,NTHI,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,MTDR,VG,LUCK,GROV,EVH,BUSE,IRIX,BLNE,RNXT | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,BCDA,FG,BNL,ZOMDF,NTHI,BATRA,ATLO,OPAL,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,AWRE,IRIX,BUSE,RNXT,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,BCDA,FG,BNL,NTHI,ZOMDF,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,IRIX,BUSE,RNXT,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,FG,BNL,BCDA,ZOMDF,NTHI,BATRA,ATLO,OPAL,MRP,NEOG,PEB,LTRX,SAIC,NEWT,VG,MTDR,LUCK,EVH,RLMD,IRIX,BUSE,RNXT,BLNE | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
SUNS,FG,BNL,BCDA,ZOMDF,NTHI,BATRA,ATLO,OPAL,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,AWRE,IRIX,BUSE,BLNE,RNXT | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
BioCardia, Inc. (BCDA) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-21 -
SUNS,BNL,FG,BCDA,NTHI,ZOMDF,BATRA,ATLO,OPAL,MRP,NEOG,PEB,SAIC,INNV,NEWT,VG,MTDR,LUCK,GROV,EVH,IRIX,BUSE,BLNE,RNXT | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21
No headlines in this category right now — try “All”.